直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

We share our Insights on a regular basis.

Media Contacts
Terra Liddell
Chief Marketing Officer
Washington, DC
Email
Angela Robinson
Director of Branding and Communications
Washington, DC
Email

IP Updates

Unified Patent Court (UPC) Hub

2026

Articles

When the Classroom Goes Dark: Lessons from the Canvas Breach for Corporate Cyber Preparedness

July 8, 2026

Articles

Enforcing Your Patent Rights at Sea: A UK Perspective

June 18, 2026

Articles

EPR Academy, Part 4 of 6: Choosing Between EPR, IPR, PGR, and Reissue

July 1, 2026

Articles

Highlights and Implications of the UK Corporate Plan for the UKIPO

July 17, 2026

Webinar

Successful Strategies to Win Alice Motions and Fee Awards in Patent Cases Against Non-Practicing Entities

July 22, 2026

IP Updates

Too Concrete to Fail: Ceiva’s Guidance on the Use of Sufficiently Concrete Structures to Overcome Section 101 Rejections

July 28, 2026

At the PTAB Blog

Deadline Evolution: Director Extends Deadline for Requesting Director Review of Institution Grants to 30 Days

June 30, 2026

Federal Circuit IP Blog

“2” Does Not Provide Written Description Support for “1”: Federal Circuit Affirms District Court’s Invalidation of Patent

July 8, 2026

Articles

California Reaches Record $12.75 Million CCPA Settlement with General Motors Over Driver Data

June 4, 2026

Never miss an Insight.

Sign up

Recent Insights

to

Articles

Potential Implications of Inflation Reduction Act on Pharmaceutical Patent Litigation

Potential Implications of Inflation Reduction Act on Pharmaceutical Patent Litigation Potential Implications of Inflation Reduction Act on Pharmaceutical Patent Litigation

May 1, 2023

Bloomberg Law

Federal Circuit IP Blog

Assignor Estoppel Has “No Place” in IPR Proceedings Assignor Estoppel Has “No Place” in IPR Proceedings

November 27, 2018

Federal Circuit IP Blog

Federal Circuit Cautions Against Omitting Preamble Transition Words in Claim Drafting Federal Circuit Cautions Against Omitting Preamble Transition Words in Claim Drafting

November 16, 2018

Federal Circuit IP Blog

Lack of Reasonable Expectation of Success Prohibits Finding of Interference-in-Fact Lack of Reasonable Expectation of Success Prohibits Finding of Interference-in-Fact

October 4, 2018

Articles

Most-Favored-Licensee Provision Did Not Provide a License to Newly-Acquired Patents or Patents that Did Not Trigger the Provision Most-Favored-Licensee Provision Did Not Provide a License to Newly-Acquired Patents or Patents that Did Not Trigger the Provision

March 7, 2017

LES Insights

Articles

Court Finds an Agreement Not-to-Sue Is a Patent License Despite Language to the Contrary Court Finds an Agreement Not-to-Sue Is a Patent License Despite Language to the Contrary

June 14, 2016

LES Insights

Articles

Consulting Agreement Did Not Assign Patent Rights from Pre-Agreement Contributions Consulting Agreement Did Not Assign Patent Rights from Pre-Agreement Contributions

March 15, 2016

LES Insights

Articles

Accused Infringer May Seek an IPR Despite Patent Owner's Inability to Raise an Assignor Estoppel Defense in the IPR Accused Infringer May Seek an IPR Despite Patent Owner's Inability to Raise an Assignor Estoppel Defense in the IPR

October 13, 2015

LES Insights

Articles

Court Grants Stay of Entire Case Involving 11 Patents While Patent Office Conducts Inter Partes Review Proceedings on Two of the Patents Court Grants Stay of Entire Case Involving 11 Patents While Patent Office Conducts Inter Partes Review Proceedings on Two of the Patents

June 30, 2015

LES Insights

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP